Niagen Bioscience Inc (FRA:OCD1)
€ 2.6 +0.22 (+9.24%) Market Cap: 206.17 Mil Enterprise Value: 150.04 Mil PE Ratio: 19.10 PB Ratio: 3.29 GF Score: 68/100
Sorry the transcript is not found. Please try another one.